Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study

British Medical Journal

Volumn 315, Issue 7115, 1997, Pages 1045-1049

  Kuusisto, Johanna ^a   Koivisto, Keijo ^a   Mykkänen, Leena ^a   Helkala, Eeva Liisa ^a   Vanhanen, Matti ^a   Hänninen, Tuomo ^a   Kervinen, Kari ^b   Kesäniemi, Y Antero ^b   Riekkinen, Paavo J ^a   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; GLUCOSE; INSULIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SOCIOECONOMICS; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 9844229370     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7115.1045     Document Type: Article

References (32)

1. Corder EH, Saunders AM, Strittmacher WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
2. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-8.
3. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. ApoE4-associated Alzheimer's disease risk is modified by alpha-1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-8.
4. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MAC elderly hypertension trial. Neurology 1994;44:97-104.
5. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 1995;45:1092-6.
6. Razay G, Wilcock K. Hyperinsulinemia and Alzheimer's disease. Age Aging 1994;23:396-9.
7. Kilander L, Boberg M, Lithell H. Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta Neurol Scand 1993;87:294-8.
8. Landin K, Blennow K, Wallin A, Gottfries CG. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med 1993;233:357-63.
9. Ott A, Stolk RP, Hofman A, van Harskamp f, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 1996;39:1392-7.
10. Hofman A, Ott A, Breteler M, Bots ML, Slooter AJC, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
11. Mykkänen L, Laakso M, Uusïtupa M, Pyörälä K. Prevalence of diabetes and impaired glucose tolerance in eldery subjects and their association with obesity and family history of diabetes. Diabetes Care 1990;11: 1099-105.
12. World Health Organization. WHO study group on diabetes mellitus. World Health Organ Tech Rep Ser 1985:727.
13. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentration. J Lipid Res 1986;27:227-35.
14. Menzel HJ, Utermann G. Apolipoprotein E phenotyping from serum by western blotting. Electrophoresis 1986;7:492-4.
15. Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody precipitate. Biochem J 1963;8:137-46.
16. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. Standards and procedures for measurement and classification. Boston: John Wright, 1982.
18. World Health Organisation. MONICA manual. CVD/MNC. Geneva: World Health Organisation, 1982 and 1990.
19. Palomäki P, Miettinen H, Mustaniemi H, Lehto S, Pyörälä K, Mähönen M, et al. Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis. J Clin Epidemiol 1994;47:659-66.
20. Weinfeld FD, ed. The national survey of stroke. Stroke 1981;12(suppl 1):32-7.
21. Koivisto K, Helkala E-L, Reinikainen KJ, Hänninen T, Mykkänen L, Laakso M, et al. Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests. J Geriatr Psych Neurol 1992;5:162-71.
22. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening of dementia by memory testing. Neurology 1988;38:900-3.
23. Warrington EK, James M, Kinsbourne M. Drawing disability in relation to laterality of cerebral lesion. Brain 1996;89:53-82.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorder. 3rd ed, rev. Washington: American Psychiatric Association, 1987. (DSM-III-R)
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA workgroup under the auspices of the department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-44.
26. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
27. Brownlee M. Advanced protein glycosylation in diabeles and aging. Ann Rev Med 1995;46:223-34.
28. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 1994;91:4766-70.
29. Kuusisto J, Koivisto K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993;22:771-9.
30. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 1993;92:1824-30.
31. Baskin DG, Figlewicz DP, Woods SC, Porte D Jr, Dorsa DM. Insulin in the brain. Annu Rev Physiol 1987;49:335-47.
32. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991;11:1068-76.